Table 1. Baseline Characteristics of the Study Population .
| Characteristics | CustodiolHTK (n=14) | Local HTK (n=14) | Mean Difference (95% CI) | Effect Size (95% CI) | P Value |
| Age, years | 48.0 ± 8.1 | 46.2 ± 13.9 | 1.7 (-7.1–10.5) | 0.15 (-0.59–0.89) | 0.694 |
| Sex, No. (%) | |||||
| Male | 11 (78.6) | 9 (64.3) | — | — | 0.678 |
| Female | 3 (21.4) | 5 (35.7) | — | — | |
| BMI, kg/m2 | 24.9 ± 2.3 | 24.9 ± 3.3 | -0.007 (-2.2–2.2) | -0.002 (-0.74–0.73) | 0.995 |
| Blood type, No. (%) | |||||
| O | 8 (57.1) | 8 (57.1) | — | — | 0.900 |
| A | 3 (21.4) | 3 (21.4) | — | — | |
| B | 2 (14.3) | 2 (14.3) | — | — | |
| AB | 1 (7.1) | 1 (7.1) | — | — | |
| Underlying disease, No. (%) | |||||
| Cardiac | 1 (7.1) | 0 | — | — | 0.633 |
| Diabetes | 2 (14.3) | 4 (28.6) | — | — | |
| Renal failure | 1 (7.1) | 1 (7.1) | — | — | |
| Duration of liver disease, months | 55.1 ± 46.5 | 54.4 ± 64.2 | 0.6 (-51.1–52.3) | 0.01 (-0.84–0.86) | 0.979 |
| Cause of liver failure, No. (%) | |||||
| Nonalcoholic steatohepatitis | 3 (21.4) | 4 (28.6) | — | — | 0.464 |
| Primary sclerosing cholangitis | 4 (28.5) | 0 | — | — | |
| Cryptogenic | 0 | 2 (14.3) | — | — | |
| Autoimmune hepatitis | 2 (14.3) | 1 (7.1) | — | — | |
| Hepatitis C virus | 1 (7.1) | 0 | — | — | |
| Alcoholic hepatitis | 0 | 1 (7.1) | — | — | |
| Budd Chiari | 0 | 1 (7.1) | — | — | |
| Hepatitis B virus | 2 (14.3) | 1 (7.1) | — | — | |
| Hepatitis B virus + Hepatocellular carcinoma | 1 (7.1) | 0 | — | — | |
| Hyperoxalemia | 0 | 1 (7.1) | — | — | |
| Primary biliary cirrhosis | 1 (7.1) | 1 (7.1) | — | — | |
| Primary sclerosing cholangitis + Hepatocellular carcinoma | 0 | 1 (7.1) | — | — | |
| Wilson's disease | 0 | 1 (7.1) | — | — | |
| MELD score | 18.3 ± 5.1 | 17.1 ± 3.9 | 1.1 (-2.5–4.9) | 0.25 (-0.53–1.04) | 0.525 |
| Type of organ transplantation, No. (%) | |||||
| Deceased | 13 (92.9) | 10 (71.4) | — | — | 0.326 |
| Living | 1 (7.1) | 4 (28.6) | — | — | |
| Type of hepatectomy, No. (%) | |||||
| Piggyback | 11 (78.6) | 12 (85.7) | — | — | 0.622 |
| Standard | 3 (21.4) | 2 (14.3) | — | — | |
| Warm ischemic time; minutes | 36.2 ± 10.2 | 36.9 ± 5.2 | -4.4 (-14.4–5.4) | -0.08 (-0.82–0.65) | 0.818 |
| Cold ischemic time; minutes | 243.5 ± 190.3 | 197.5 ± 183.3 | 214.2 (-143.3–51.9) | 0.24 (-0.50–0.98) | 0.520 |
BMI, body mass index; MELD, model for end-stage liver disease.
All plus-minus are means and standard deviation unless stated otherwise.